🔗 Hydroxychloroquine
Articles (20)
-
Hydroxychloroquine for treatment of SARS-CoV-2 infection? Improving our confidence in a model-based approach to dose selection.
👤 Arnold, Samuel Lm 👤 Buckner, Frederick ⏰ 2020 📚 Clin Transl Sci
-
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
👤 Atluri, Sairam 👤 Manchikanti, Laxmaiah 👤 Hirsch, Joshua A ⏰ 2020 📚 Pain Physician
- Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
-
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
👤 Devaux, Christian A 👤 Rolain, Jean-Marc 👤 Colson, Philippe 👤 Raoult, Didier ⏰ 2020 📚 Int J Antimicrob Agents
-
Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
👤 Fantini, Jacques 👤 Scala, Coralie Di 👤 Chahinian, Henri 👤 Yahi, Nouara ⏰ 2020 📚 Int J Antimicrob Agents
-
A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.
👤 Ferrey, Antoney J 👤 Choi, Grace 👤 Hanna, Ramy M 👤 Chang, Yongen 👤 Tantisattamo, Ekamol 👤 Ivaturi, Kaushik 👤 Park, Elisa 👤 Nguyen, Lawrence 👤 Wang, Brian 👤 Tonthat, Sam 👤 Rhee, Connie M 👤 Reddy, Uttam 👤 Lau, Wei Ling 👤 Huang, Susan S 👤 Gohil, Shruti 👤 Amin, Alpesh N 👤 Hsieh, Lanny 👤 Cheng, Timmy T 👤 Lee, Richard A 👤 Kalantar-Zadeh, Kamyar ⏰ 2020 📚 Am J Nephrol
-
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
👤 Gautret, Philippe 👤 Lagier, Jean-Christophe 👤 Parola, Philippe 👤 Hoang, Van Thuan 👤 Meddeb, Line 👤 Mailhe, Morgane 👤 Doudier, Barbara 👤 Courjon, Johan 👤 Giordanengo, Valerie 👤 Vieira, Vera Esteves 👤 Dupont, Herve Tissot 👤 Honore, Stephane 👤 Colson, Philippe 👤 Chabriere, Eric 👤 La Scola, Bernard 👤 Rolain, Jean-Marc 👤 Brouqui, Philippe 👤 Raoult, Didier ⏰ 2020 📚 Int J Antimicrob Agents
- Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review.
-
Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc).
👤 Gupta, Ritesh 👤 Misra, Anoop ⏰ 2020 📚 Diabetes Metab Syndr
-
Potential therapeutic agents against COVID-19: What we know so far.
👤 Lu, Chih-Chia 👤 Chen, Mei-Yu 👤 Chang, Yuh-Lih ⏰ 2020 📚 J Chin Med Assoc
-
Macrolide treatment for COVID-19: Will this be the way forward?
👤 Ohe, Masashi 👤 Shida, Haruki 👤 Jodo, Satoshi 👤 Kusunoki, Yoshihiro 👤 Seki, Masahide 👤 Furuya, Ken 👤 Goudarzi, Houman ⏰ 2020 📚 Biosci Trends
-
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.
👤 Perinel, Sophie 👤 Launay, Manon 👤 Botelho-Nevers, Elisabeth 👤 Diconne, Eric 👤 Louf-Durier, Aurore 👤 Lachand, Raphael 👤 Murgier, Martin 👤 Page, Dominique 👤 Vermesch, Regine 👤 Thierry, Guillaume 👤 Delavenne, Xavier ⏰ 2020 📚 Clin Infect Dis
-
Clinical trials on drug repositioning for COVID-19 treatment.
👤 Rosa, Sandro G Viveiros 👤 Santos, Wilson C ⏰ 2020 📚 Rev Panam Salud Publica
-
Generalized Pustular Figurate Erythema A Newly Delineated Severe Cutaneous Drug Reaction Linked with Hydroxychloroquine.
👤 Schwartz, Robert A 👤 Janniger, Camila K ⏰ 2020 📚 Dermatol Ther
-
Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic.
👤 Scuccimarri, Rosie 👤 Sutton, Evelyn 👤 Fitzcharles, Mary-Ann ⏰ 2020 📚 J Rheumatol
-
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.
👤 Singh, Awadhesh Kumar 👤 Singh, Akriti 👤 Shaikh, Altamash 👤 Singh, Ritu 👤 Misra, Anoop ⏰ 2020 📚 Diabetes Metab Syndr
-
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
👤 Yao, Xueting 👤 Ye, Fei 👤 Zhang, Miao 👤 Cui, Cheng 👤 Huang, Baoying 👤 Niu, Peihua 👤 Liu, Xu 👤 Zhao, Li 👤 Dong, Erdan 👤 Song, Chunli 👤 Zhan, Siyan 👤 Lu, Roujian 👤 Li, Haiyan 👤 Tan, Wenjie 👤 Liu, Dongyang ⏰ 2020 📚 Clin Infect Dis
-
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
👤 Yao, Xueting 👤 Ye, Fei 👤 Zhang, Miao 👤 Cui, Cheng 👤 Huang, Baoying 👤 Niu, Peihua 👤 Liu, Xu 👤 Zhao, Li 👤 Dong, Erdan 👤 Song, Chunli 👤 Zhan, Siyan 👤 Lu, Roujian 👤 Li, Haiyan 👤 Tan, Wenjie 👤 Liu, Dongyang ⏰ 2020 📚 Clin Infect Dis
-
The epidemiology, diagnosis and treatment of COVID-19.
👤 Zhai, Pan 👤 Ding, Yanbing 👤 Wu, Xia 👤 Long, Junke 👤 Zhong, Yanjun 👤 Li, Yiming ⏰ 2020 📚 Int J Antimicrob Agents
-
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.
👤 Zhou, Dan 👤 Dai, Sheng-Ming 👤 Tong, Qiang ⏰ 2020 📚 J Antimicrob Chemother